DRG 014
Medical DRGAllogeneic Bone Marrow Transplant
What is MS-DRG 014?
MS-DRG 014 is a Medical Medicare Severity Diagnosis Related Group. For FY 2026 it carries a relative weight of 12.0179 with a geometric mean length of stay of 25.7 days and an arithmetic mean of 28.7 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
FY 2026 Payment Data
Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).
Linked ICD-10-PCS Procedure Mappings
- 30233G2
Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233G3
Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233G4
Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233U2
Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233U3
Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233U4
Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233X2
Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233X3
Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233X4
Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233Y2
Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233Y3
Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30233Y4
Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
BillableSection 3 - 30243G2
Transfusion of Allogeneic Related Bone Marrow into Central Vein, Percutaneous Approach
BillableSection 3 - 30243G3
Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Percutaneous Approach
BillableSection 3 - 30243G4
Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Percutaneous Approach
BillableSection 3 - 30243U2
Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243U3
Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243U4
Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243X2
Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243X3
Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243X4
Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243Y2
Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243Y3
Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - 30243Y4
Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
BillableSection 3 - XW133C8
Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
BillableSection X - XW143C8
Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8
BillableSection X
